Status:
NOT_YET_RECRUITING
The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborating Sponsors:
Peking Union Medical College Hospital
Shanghai Chest Hospital
Conditions:
Lung Cancer
Red Blood Cells
Eligibility:
All Genders
18+ years
Brief Summary
This study plan to enroll 852 patients with pulmonary nodules smaller than 3 cm in diameter, whose DNA and RNA will be extracted from mature red blood cells isolated from peripheral blood. The DNA 5-m...
Detailed Description
This is a prospective, multi-center, observational, cohort study and seeks to enroll 852 participants with pulmonary nodules smaller than 3 cm in diameter from 4 hospitals in China. Each participant ...
Eligibility Criteria
Inclusion
- Pulmonary nodule is ≤3cm;
- Subjects suspected of lung cancer;
- Diagnosis or treatment by biopsy or surgery within 60 days;
- Signed informed consent.
Exclusion
- History of malignant tumors;
- Received anti-tumor therapy;
- Can't collect the histopathological results or the pathological results are metastatic cancer;
- Can't obtain detection information of red blood cells;
- Pregnancy or lactating female；
- Other situations not suitable for the study.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
852 Patients enrolled
Trial Details
Trial ID
NCT05380999
Start Date
May 1 2022
End Date
March 1 2026
Last Update
May 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.